Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976

Colombo GL, Caruggi M, Di Matteo, et al

Neuropsychiatric Disease and Treatment 2008, 4:1283-1283

Published Date: 5 December 2008